l-carnitine and ammonia levels Management of late onset urea cycle disorders—a remaining challenge for the intensivist? | Annals of Intensive Care The treatment effect of l-carnitine

Wohlfarth C, Schmitteckert S, Hrtle JD, Houghton LA, Dweep H, Fortea M, et al

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

The inflammatory response induced by oxidative stress may play a crucial role in the pathogenesis of cerebral vasospasm (CVS) following subarachnoid hemorrhage (SAH) (Wu et al., 2011)

In our chair, the patient who benefits most is someone who: Has the specific anatomical or skin concern this treatment addresses Has reasonable expectations about result magnitude and timeline Is willing to do the maintenance and aftercare Doesnt need a different treatment that would be more appropriate If any of the above are missing, we recommend something else